Close Menu

By Edward Winnick

NEW YORK (GenomeWeb News) - Fluidigm officials said Monday that the firm is focusing on growing its business and inking partnerships as it keeps its eye on a potential initial public offering.

The microfluidics and array manufacturer was forced to withdraw its proposed IPO amid the market meltdown a year ago. At the time, company officials said that Fluidigm would go public once the markets stabilized.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Aug
13
Sponsored by
10x Genomics

This webinar will discuss a study that combined single-cell gene expression and spatial gene expression to understand the evolution of sepsis in the kidney at the cellular and molecular level.